Mammalian hair, roof leaks: Novo Nordisk’s site in Indiana under FDA scrutiny once againnews2026-06-04T16:14:22+00:00June 4th, 2026|Endpoints News|
Hikma to funnel $267M to Ohio; Cingulate gets CRL for ADHD drug news2026-06-04T15:42:37+00:00June 4th, 2026|Endpoints News|
Lilly, Boehringer retrench in Germany on proposed health spending cutsnews2026-06-04T15:13:21+00:00June 4th, 2026|Endpoints News|
Supreme Court sides with Hikma in ‘skinny label’ casenews2026-06-04T15:04:41+00:00June 4th, 2026|Endpoints News|
Novo Holdings backs European fund; Alnylam sends second obesity drug into clinicnews2026-06-04T14:48:51+00:00June 4th, 2026|Endpoints News|
Parabilis Medicines charts $413M IPO to back peptide pipelinenews2026-06-04T13:04:21+00:00June 4th, 2026|Endpoints News|
ADC Therapeutics’ confirmatory data for Zynlonta muddied by death ratesnews2026-06-04T11:01:18+00:00June 4th, 2026|Endpoints News|
ADC biotech Ona Therapeutics secures $86.6M in Series B raisenews2026-06-04T07:00:08+00:00June 4th, 2026|Endpoints News|
Alnylam to pay $30M upfront to AI startup Inceptive in RNA R&D dealnews2026-06-03T20:45:47+00:00June 3rd, 2026|Endpoints News|
